This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
GLN-DAPAGLIFLOZIN
GLENMARK PHARMACEUTICALS CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GLN-DAPAGLIFLOZIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GLN-DAPAGLIFLOZIN 10MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GLN-DAPAGLIFLOZIN not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02519860
Strength
10MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
DAPAGLIFLOZIN
Tier
Unrated
Last Updated
2026-10-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
GLN-DAPAGLIFLOZIN has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
30MG · DIN 02518910
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
600MG · DIN 02410990
800MG · DIN 02411008
40MG · DIN 02469820
20MG · DIN 02469812